IP Library › Assignment 023355/0313
Patent Assignment
Reel/Frame 023355/0313

Change of Name

Recorded: 2009-10-12 Pages: 6
Assignor
SCHERING AKTIENGESELLSCHAFT
Executed: 2006-12-29
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties (3)
Novel Tissue Factor Targeted Thrombomodulin Fusion Proteins as Anticoagulants
Patent: 7,250,168 →
Application: 10/427,805 →
Publication: US 2004/0063632
Polynucleotides Encoding Anticoagulant Fusion Proteins
Patent: 7,622,457 →
Application: 11/766,155 →
Publication: US 2008/0019985
Methods of Using Novel Tissue Factor Targeted Thrombomodulin Fusion Proteins as Anticoagulants
Patent: 7,622,122 →
Application: 11/766,160 →
Publication: US 2008/0020965
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 23, 2004
From: LIGHT, DAVID; MCLEAN, KIRK
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 014288/0574 →
Change of Name Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
Assignment of Assignor's Interest Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →